FEPI:NSD-REX FANG & Innovation Equity Premium Income ETF (USD)

ETF | Others |

Last Closing

USD 52.95

Change

+0.89 (+1.71)%

Market Cap

USD 0.06B

Volume

0.10M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+1.01 (+0.51%)

USD 27.30B
ACWI iShares MSCI ACWI ETF

-0.21 (-0.19%)

USD 18.79B
IBIT iShares Bitcoin Trust

-0.60 (-1.58%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

-0.14 (-0.79%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.02 (+0.04%)

USD 14.10B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.02 (+0.08%)

USD 2.80B
IBTF iShares iBonds Dec 2025 Term T..

+0.02 (+0.09%)

USD 2.31B
NVDL GraniteShares 2x Long NVDA Dai..

+2.93 (+3.75%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

+0.14 (+0.22%)

USD 2.01B

ETFs Containing FEPI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.34% 22% F 43% F
Dividend Return 8.42% 98% N/A 99% N/A
Total Return 4.09% 61% D- 64% D
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.06B 56% F 30% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike